Financhill
Back

Roche Holding AG Quote, Financials, Valuation and Earnings

Roche Holding AG Price Quote

$287.01
-0.03 (-0.01%)
(Updated: November 25, 2024 at 5:40 PM ET)

Roche Holding AG Key Stats

Sell
22
Roche Holding AG (RHHVF) is a Sell

Day range:
$281.76 - $287.04
52-week range:
$233.12 - $340.88
Dividend yield:
3.81%
P/E ratio:
18.01
P/S ratio:
3.41
P/B ratio:
7.1%

Volume:
21.1K
Avg. volume:
5.1K
1-year change:
8.01%
Market cap:
$228.7B
Revenue:
$67.3B
EPS:
$14.76

How Much Does Roche Holding AG Make?

Is Roche Holding AG Growing As A Company?

  • What Is Roche Holding AG's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Roche Holding AG's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.02%

Roche Holding AG Stock Price Performance

What Is Roche Holding AG 52-Week High & Low?

Roche Holding AG Price To Free Cash Flow

Is It Risky To Buy Roche Holding AG?

  • How Much Debt Does Roche Holding AG Have?
    Total long term debt quarterly is $38.3B
  • How Much Cash Does Roche Holding AG Have?
    Cash and short term investments quarterly total is $9.8B
  • What Is Roche Holding AG’s Book Value Per Share?
    Book value per share is 40.41

Is Roche Holding AG Cash Flow Positive?

  • What Is RHHVF Cash Flow From Operations?
    Cash flow from operations (TTM) is $18B
  • What Is Roche Holding AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.5B
  • What Is Roche Holding AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$14.6B

Roche Holding AG Return On Invested Capital

  • Is Management Doing A Good Job?
    RHHVF return on invested capital is 16.82%
  • What Is Roche Holding AG Return On Assets?
    ROA measures how assets are converting to revenues and is 11.53%
  • What Is RHHVF Return On Equity?
    ROE is a measure of profitability and is 32.32%

Roche Holding AG Earnings Date & Stock Price

Roche Holding AG Competitors

  • Who Are Roche Holding AG's Competitors?
    Below is a list of companies who compete with Roche Holding AG or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

Roche Holding AG Dividend Yield

Roche Holding AG Analyst Estimates

YoY Growth Past Surprise
EPS: 1.67% 0%
Revenue: 4.17% 1.49%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many RHHVF shares are owned by institutional investors?
    320.3M RHHVF shares are owned by institutional investors
  • How many RHHVF shares are owned by insiders?
    0 RHHVF shares are owned by insiders